Panax quinquefolium saponin liposomes prepared by passive drug loading for improving intestinal absorption

References

• Jayakodi M, Lee SC, Park HS, et al. Transcriptome profiling and comparative analysis of Panax ginseng adventitious roots. J Ginseng Res. 2014;38(4):278–288.
   PubMed Web of Science ®Google Scholar
• Chen XJ, Zhang XJ, Shui YM, et al. Anticancer activities of protopanaxadiol- and protopanaxatriol-type ginsenosides and their metabolites. Evid Based Complement Alternat Med. 2016;2016:5738694.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu Y, Yang J, et al. Discovery, semisynthesis, biological activities, and metabolism of ocotillol-type saponins. J Ginseng Res. 2017;41(3):373–378.
   PubMed Web of Science ®Google Scholar
• Pan W, Xue B, Yang C, et al. Biopharmaceutical characters and bioavailability improving strategies of ginsenosides. Fitoterapia. 2018;129:272–282.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Q, Xu Y, et al. Ginsenoside Rg1 protects against oxidative stress-induced neuronal apoptosis through myosin IIA-actin related cytoskeletal reorganization. Int J Biol Sci. 2016;12(11):1341–1356.
   PubMed Web of Science ®Google Scholar
• Gao ZW, Ju RL, Luo M, et al. The anxiolytic-like effects of ginsenoside Rg2 on an animal model of PTSD. Psychiatry Res. 2019;279:130–137.
   PubMed Web of Science ®Google Scholar
• Hou J, Xue J, Wang Z, et al. Ginsenoside Rg3 and Rh2 protect trimethyltin-induced neurotoxicity via prevention on neuronal apoptosis and neuroinflammation. Phytother Res. 2018;32(12):2531–2540.
   PubMed Web of Science ®Google Scholar
• Li N, Liu Y, Li W, et al. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer’s disease. J Ginseng Res. 2016;40(1):9–17.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang J, Liu C, et al. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer’s disease-type pathologies in SAMP8 mice. Pharmacol Res. 2019;139:512–523.
   PubMed Web of Science ®Google Scholar
• Fu K, Lin H, Miyamoto Y, et al. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens. Psychopharmacology. 2015;233(5):831–840.
   PubMed Web of Science ®Google Scholar
• Wang JY, Yang JY, Wang F, et al. Neuroprotective effect of pseudoginsenoside-F11 on a rat model of Parkinson’s disease induced by 6-hydroxydopamine. Evid Based Complement Alternat Med. 2013;2013:152798.
   PubMed Web of Science ®Google Scholar
• Zhu D, Wu L, Li C-R, et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem. 2009;108(1):117–124.
   PubMed Web of Science ®Google Scholar
• Leung KW, Cheng YK, Mak NK, et al. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett. 2006;580(13):3211–3216.
   PubMed Web of Science ®Google Scholar
• Qu D-F, Yu H-J, Liu Z, et al. Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Vet Parasitol. 2011;179(1–3):28–34.
   PubMed Web of Science ®Google Scholar
• Tang F. Inhibition of TNF-α mediated NF-kB activation by ginsenoside Rg1 contributes the attenuation of cardiac hypertrophy induced by abdominal aorta coarctation. Cardiovasc Pharmacol. 2016;68:8.
   Web of Science ®Google Scholar
• Li CT, Wang HB, Xu BJ. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2. Pharm Biol. 2013;51(8):1077–1080.
   PubMed Web of Science ®Google Scholar
• Luo X, Wang C-Z, Chen J, et al. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol. 2008;32(5):975–983.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Z, Liu J, et al. Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice. Int Immunopharmacol. 2019;72:98–111.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Yang Y, Yang Y, et al. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune. Biomed Pharmacother. 2017;96:378–383.
   PubMed Web of Science ®Google Scholar
• Li Y, Hu H, Li Z, et al. Pharmacokinetic characterizations of ginsenoside ocotillol, RT5 and F11, the promising agents for Alzheimer’s disease from American ginseng, in rats and beagle dogs. Pharmacology. 2019;104(1–2):7–20.
   PubMed Web of Science ®Google Scholar
• Li X, Wang G, Sun J, et al. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional Chinese medicine (TCM) in rats. Biol Pharm Bull. 2007;30(5):847–851.
   PubMed Web of Science ®Google Scholar
• Feng L, Wang L, Hu C, et al. Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats. Arch Pharm Res. 2010;33(12):1975–1984.
   PubMed Web of Science ®Google Scholar
• Xu MJ, Wang GJ, Xie HT, et al. Determination of ginsenoside Rg2 in rat plasma by high-performance liquid chromatography-mass spectrometry after solid-phase extraction. Anal Lett. 2006;39(1):113–126.
   Web of Science ®Google Scholar
• Xie HT, Wang GJ, Sun JG, et al. High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;818(2):167–173.
   PubMed Web of Science ®Google Scholar
• Chagas CM, Moss S, Alisaraie L. Drug metabolites and their effects on the development of adverse reactions: revisiting Lipinski’s Rule of Five. Int J Pharm. 2018;549(1–2):133–149.
   PubMed Web of Science ®Google Scholar
• Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015;115(19):10938–10966.
   PubMed Web of Science ®Google Scholar
• Adler-Moore J, Proffitt RT. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J Antimicrob Chemother. 2002;49(suppl_1):21–30.
   PubMedGoogle Scholar
• Forssen EA. The design and development of DaunoXome® for solid tumor targeting in vivo. Adv Drug Delivery Rev. 1997;24(2–3):133–150.
   Web of Science ®Google Scholar
• Hu S, Niu M, Hu F, et al. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Int J Pharm. 2013;441(1–2):693–700.
   PubMed Web of Science ®Google Scholar
• Wan JB, Li SP, Chen JM, et al. Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD. J Sep Sci. 2007;30(6):825–832.
   PubMed Web of Science ®Google Scholar
• Ren T, Wang Q, Xu Y, et al. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. J Control Release. 2018;269:423–438.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhai B, Fan Y, et al. Intestinal absorption mechanisms of araloside A in situ single-pass intestinal perfusion and in vitro Caco-2 cell model. Biomed Pharmacother. 2018;106:1563–1569.
   PubMed Web of Science ®Google Scholar
• Siepmann J. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev. 2001;48(2–3):229–247.
   PubMed Web of Science ®Google Scholar
• Andreucci D, Cirillo ENM, Colangeli M, et al. Fick and Fokker–Planck diffusion law in inhomogeneous media. J Stat Phys. 2018;174(2):469–493.
   Web of Science ®Google Scholar
• Qiu D, An X. Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation. Colloids Surf B Biointerfaces. 2013;104:326–329.
   PubMed Web of Science ®Google Scholar
• Kanamala M, Palmer BD, Wilson WR, et al. Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes. Int J Pharm. 2018;548(1):288–296.
   PubMedGoogle Scholar
• Zhuang J, Wang D, Li D, et al. The influence of nanoparticle shape on bilateral exocytosis from Caco-2 cells. Chin Chem Lett. 2018;29(12):1815–1818.
   Web of Science ®Google Scholar
• Xia D, He Y, Li Q, et al. Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium. J Control Release. 2018;269:159–170.
   PubMed Web of Science ®Google Scholar
• Li D, Zhuang J, Yang Y, et al. Loss of integrity of doxorubicin liposomes during transcellular transportation evidenced by fluorescence resonance energy transfer effect. Colloids Surf B Biointerfaces. 2018;171:224–232.
   PubMed Web of Science ®Google Scholar
• Li T, Cipolla D, Rades T, et al. Drug nanocrystallisation within liposomes. J Control Release. 2018;288:96–110.
   PubMed Web of Science ®Google Scholar
• Fan Q, Zhang Y, Hou X, et al. Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate-mediated liposomes: preparation by supercritical fluid technology and evaluation in vitro and in vivo. Int J Pharm. 2018;552(1–2):360–370.
   PubMedGoogle Scholar
• Ren WY, Wu KF, Li X, et al. Age-related changes in small intestinal mucosa epithelium architecture and epithelial tight junction in rat models. Aging Clin Exp Res. 2014;26(2):183–191.
   PubMed Web of Science ®Google Scholar